Aytu BioScience Inc (AYTU) Live Share Price, Invest From India

Aytu BioScience Inc Stock Performance

as on May 16, 2026 at 5:27 am IST

Day's Low
Day's High
$2.17
Day's Price Range
$2.27
$2.19
0.91%
Downside
3.65%
Upside
52 Week's Low
52 Week's High
$1.46
52-Week Price Range
$3.07
$2.19
33.33%
Downside
39.95%
Upside

Aytu BioScience Inc share price movements today

Previous Close: $2.27
Open: $2.27
Volume: 682.5K
Day's Low - High: $2.17 - $2.27
52 Week Low - High: $1.46 - $3.07

Aytu BioScience Inc Historical Returns

1 Month Return: -12.36 %
3 Month Return: + 6.57 %
1 Year Return: -12.36 %
3 Year Return: + 26.82 %
5 Year Return: -97.89 %

Aytu BioScience Inc Stock Fundamentals & Key Indicators

Check Aytu BioScience Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.8M

EPS (TTM)

-1.24

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

4.0M

Revenue (TTM)

62.6M

Profit Margin

-39.02%

Return On Equity TTM

-109.23%

Aytu BioScience Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aytu BioScience Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Aytu BioScience Inc	BUY	$23.8M	-97.89%	NA	-39.02%
United Therapeutics Corporation	BUY	$24.4B	NA	21.41	40.62%
Viatris Inc	HOLD	$20.2B	7.88%	NA	-2.04%
Haleon plc	BUY	$39.5B	NA	17.82	15.11%
Zoetis Inc	BUY	$31.2B	-56.19%	12.19	28.04%

Stock Returns calculator for Aytu BioScience Inc Stock including INR - Dollar returns

The Aytu BioScience Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Aytu BioScience Inc investment value today

Current value as on today

₹94,845

Returns

-₹5,155

(-5.15%)

Returns from Aytu BioScience Inc Stock

-₹15,444 (-15.44%)

Dollar Impact

₹10,289 (+10.29%)

Analyst Recommendation on Aytu BioScience Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Aytu BioScience Inc. Average target price of $9.33

Aytu BioScience Inc Share Price Target

Get share price movements and forecasts by analysts on Aytu BioScience Inc.

What analysts predicted

76.53%UPSIDE

Target Price

$9.33

Current Price

$2.19

Analyzed by

7 Analysts

Target

$9.33

Aytu BioScience Inc target price $9.33, a slight upside of 76.53% compared to current price of $2.19. According to 7 analysts rating.

Indian Investors' Interest in Aytu BioScience Inc Stock

Search interest for Aytu BioScience Inc Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 15, 2026 to May 15, 2026

Change:-33% versus previous 30 day period

Aytu BioScience Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	18	14	17	16	16	18	15	13	15	12
Gross Profit	14	10	11	11	10	12	10	9	9	7
Operating Income	3	-1	-3	0	-1	2	-7	-1	-1	-4
EBITDA	4	1	-5	3	2	6	-17	3	-9	-4
Interest Expense	1	1	4	0	1	0	0	0	0	0
Depreciation	2	1	1	1	1	1	1	0	0	-
Income Before Tax	1	-1	-3	1	0	3	-19	1	-10	-5
Income Tax Expense	0	0	0	0	0	0	0	-	-	0
Net Income	0	-2	-4	1	0	3	-19	1	-10	-5
Net Profit Margin	-1.17%	-20.58%	-25.68%	8.89%	4.86%	21.65%	-130.94%	14.15%	-69.79%	-45.27%

Aytu BioScience Inc Annual Profit & Loss

All numbers in Millions USD

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	2	3	3	7	27	65	96	107	65	66
Gross Profit	1	1	1	5	19	29	50	66	49	45
Operating Income	-21	-20	-19	-16	-21	-58	-109	-17	-1	-7
EBITDA	-21	-18	-15	-14	-12	-29	-27	-3	1	-4
Interest Expense	5	2	0	-	-	37	147	4	4	3
Depreciation	-	4	2	2	6	9	10	4	8	5
Income Before Tax	-28	-22	-10	-27	-13	-58	-108	-17	-10	-13
Income Tax Expense	8	1	-2	20	-9	0	0	0	2	0
Net Income	-28	-22	-10	-47	-13	-58	-108	-17	-15	-13
Net Profit Margin	-1099.73%	-698.67%	-278.36%	-644.33%	-49.29%	-88.81%	-112.53%	-15.88%	-24.31%	-20.43%

Aytu BioScience Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-2	-4	1	0	3	-19	1	-10	-5
Operating Cash Flow	0	0	-1	2	-6	2	0	3	-4
Investing Cash Flow	0	0	0	0	0	-3	-	0	-
Financing Cash Flow	0	1	0	-2	4	12	2	-6	0
Change in Cash	0	0	0	0	-2	12	1	-2	-3

Aytu BioScience Inc Annual Cash Flow

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-22	-10	-27	-13	-58	-108	-17	-15	-13
Operating Cash Flow	-13	-15	-13	-28	-25	-28	-5	-1	-1
Investing Cash Flow	-3	0	-1	-5	-2	-3	0	0	-2
Financing Cash Flow	10	22	19	71	30	1	8	-1	15
Change in Cash	-7	6	4	37	1	-30	3	-2	10

Global Institutional Holdings in Aytu BioScience Inc

Funds	Holdings
Northern Trust Corp	0.18%
Citadel Advisors Llc	0.14%
Stonepine Capital Management Llc	7.58%
JAFFETILCHIN INVESTMENT PARTNERS, LLC	0.16%
Vanguard Group Inc	2.6%

See all

Insights on Aytu BioScience Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -10.58M → -5.61M (in $), with an average increase of 88.4% per quarter
NO EFFECT
Against Peers
In the last 1 year, Viatris Inc. has given 96.4% return, outperforming this stock by 108.8%
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 84.2% return, outperforming this stock by 57.4%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 15.16M → 12.41M (in $), with an average decrease of 18.2% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, AYTU stock has moved down by -9.2%

About Aytu BioScience Inc

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.

Organisation	Aytu BioScience Inc
Headquarters	Denver Corporate Center III, Denver, CO, United States, 80237
Industry	Drug Manufacturers - Specialty & Generic
CEO	Mr. Joshua R. Disbrow
E-voting on shares	Click here to vote

Key Management of Aytu BioScience Inc

Name	Title
Mr. Joshua R. Disbrow	CEO & Director
Mr. Ryan J. Selhorn CPA	CFO, Corporate Secretary & Treasurer
Mr. Jarrett T. Disbrow Ph.D.	Chief Business Officer
Mr. Greg Pyszczymuka	Chief Commercial Officer
Ms. Margaret Cabano	Vice President of Operations
Dr. Gerwin Westfield Ph.D.	Senior Vice President of Scientific Affairs

FAQs

What is Aytu BioScience Inc share price today?

Aytu BioScience Inc share price today is $2.19 as on May 15, 2026 at 11:57 pm IST. Aytu BioScience Inc share today touched a day high of $2.27 and a low of $2.17.

What is the 52 week high and 52 week low for Aytu BioScience Inc share?

Aytu BioScience Inc share touched a 52 week high of $3.07 on January 5, 2026 and a 52 week low of $1.46 on June 5, 2025. Aytu BioScience Inc stock price today i.e. May 15, 2026 at 11:57 pm IST is trending at $2.19,which is 28.55% down from its 52 week high and 50.00% up from its 52 week low.

What is Aytu BioScience Inc's market capitalisation today?

Aytu BioScience Inc market capitalisation is $0.00T as on May 15, 2026 at 11:57 pm IST.

How to invest in Aytu BioScience Inc Stock (AYTU) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Aytu BioScience Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aytu BioScience Inc Shares that will get you 0.6849 shares as per Aytu BioScience Inc share price of $2.19 per share as on May 15, 2026 at 11:57 pm IST.

What is the minimum amount required to buy Aytu BioScience Inc Stock (AYTU) from India?

Indian investors can start investing in Aytu BioScience Inc (AYTU) shares with as little as ₹95.955 or $1 (as of May 15, 2026 at 11:59 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹959.55 in Aytu BioScience Inc stock (as per the Rupee-Dollar exchange rate as on May 15, 2026 at 11:59 pm IST). Based on Aytu BioScience Inc share’s latest price of $2.19 as on May 15, 2026 at 11:57 pm IST, you will get 4.5662 shares of Aytu BioScience Inc. Learn more about fractional shares .

What are the returns that Aytu BioScience Inc has given to Indian investors in the last 5 years?

Aytu BioScience Inc stock has given -97.89% share price returns and 30.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?